ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $10.00 price target on the stock, down previously from $15.00.
MediumReport
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $10.00 price target on the stock, down previously from $15.00.
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) had its price target lowered by analysts at HC Wainwright from $17.00 to $9.00. They now have a "buy" rating on the stock.
MediumReport
ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) had its price target lowered by analysts at HC Wainwright from $17.00 to $9.00. They now have a "buy" rating on the stock.
ASLAN Pharmaceuticals Provides TREK-DX Study Update and Highlights Potential of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients [Yahoo! Finance]
HighReport
ASLAN Pharmaceuticals Provides TREK-DX Study Update and Highlights Potential of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients [Yahoo! Finance]
ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors [Yahoo! Finance]
LowReport
ASLAN Pharmaceuticals Announces New Translational Data on Eblasakimab in COPD and Appoints Leading Respiratory Experts as Scientific Advisors [Yahoo! Finance]
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: